Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

This Study Investigate the Impact of Maternal COVID-19 Infection During Birth on the Childrens' Physical and Mental Development.

  • Read more about This Study Investigate the Impact of Maternal COVID-19 Infection During Birth on the Childrens' Physical and Mental Development.

Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection

  • Read more about Prevalence and Clinical Significance of Anti-annexin A2 Antibodies in COVID-19 Infection

A Study on Children With COVID-19 Admitted at Assiut University Children Hospital

  • Read more about A Study on Children With COVID-19 Admitted at Assiut University Children Hospital

Comprehensive Imaging Exam of Convalesced COVID-19 Patients

  • Read more about Comprehensive Imaging Exam of Convalesced COVID-19 Patients

Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

  • Read more about Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years

An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia

  • Read more about An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia

HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)

  • Read more about HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)

Genotype and Susceptibility to COVID-19

  • Read more about Genotype and Susceptibility to COVID-19

A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia

  • Read more about A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia

The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

  • Read more about The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Current page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA